Bibliography: Neurocognitive Disorders in Geriatric Psychiatry
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Articles from the bibliography that are reprinted in this issue are in bold type.
Cognitive reserve and the prevention of dementia: the role of physical and cognitive activities. Curr Psychiatry Rep 2016; 18:85Crossref, Google Scholar
:The preclinical state of AD: preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 2016; 12:292–323Crossref, Google Scholar
:Effects of citalopram on neuropsychiatric symptoms in Alzheimer’s dementia: evidence from the CitAD Study. Am J Psychiatry 2016; 173:473–480Crossref, Google Scholar
:The hidden sister of motor fluctuations in Parkinson’s disease: a review on nonmotor fluctuations. Mov Disord 2016; 31:1080–1094Crossref, Google Scholar
:Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer’s disease. Int J Geriatr Psychiatry 2016; 31:316–322Crossref, Google Scholar
:Reus VI, Fochtmann LJ, Eyler AE, et al: The American Psychiatric Association (2016) Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry 2016; 173:543–546 [executive summary; full guideline at http://psychiatryonline.org/guidelines]Google Scholar
Clinical epidemiology, evaluation, and management of dementia in Parkinson disease. Am J Alzheimers Dis Other Demen 2016; 31:585–594Crossref, Google Scholar
:Psychiatric symptoms in the initial motor stage of Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2016; 28:205–210Crossref, Google Scholar
:Frontotemporal dementia. Lancet 2015; 386:1672–1682Crossref, Google Scholar
:Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer’s disease. Alzheimers Dement 2015; 11:511–522Crossref, Google Scholar
:New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry 2015; 2:340–350Crossref, Google Scholar
:Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease. J Alzheimers Dis 2015; 47:231–242Crossref, Google Scholar
:Accelerating stem cell trials for Alzheimer's disease. Lancet Neurol 2015 Dec 15; pii: S1474-4422(15)00332-4Google Scholar
.The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan. Schizophr Bull 2015; 41:374–381Crossref, Google Scholar
:A 3D human neural cell culture system for modeling Alzheimer’s disease. Nat Protoc 2015; 10:985–1006Crossref, Google Scholar
:Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2015; 172:561–569Crossref, Google Scholar
:A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 17:2255–2263Crossref, Google Scholar
:O’Brien JT, Thomas A: Vascular dementia. Lancet 2015; 386:1698–1706Google Scholar
Long-term trajectories of cognitive deficits in schizophrenia: A critical overview. Eur Psychiatry 2015; 30:1002–1010Crossref, Google Scholar
:Walker Z, Possin KL, Boeve BF, et al: Lewy body dementias. Lancet 2015; 386:1683–1697Google Scholar
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry 2015; 86:135–143Crossref, Google Scholar
:Impact of the Alzheimer’s Disease Neuroimaging Initiative, 2004 to 2014. Alzheimers Dement 2015; 11:865–884Crossref, Google Scholar
:Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness. Am J Geriatr Psychiatry 2014; 22:1251–1261Crossref, Google Scholar
:Phase 3 trials of solanezumab and bapineuzumab for Alzheimer’s disease: Alzheimer’s Disease Cooperative Study Data Analysis and Publication Committee. N Engl J Med 2014; 370:1460Google Scholar
:AV45-A11 Study Group; AV45-A11 Study Group. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry 2014; 19:1044–1051Crossref, Google Scholar
:What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia? J Clin Psychiatry 2014; 75(Suppl 2):34–38Crossref, Google Scholar
:The tools of the trade: a state of the art “How to Assess Cognition” in the patient with Parkinson's disease. Movement Disorders 2014; 29:584–596Crossref, Google Scholar
:Effect of citalopram on agitation in Alzheimer disease: the CITAD randomized clinical trial. JAMA 2014; 311:682–691Crossref, Google Scholar
:Rabins PV, Rovner BW, Rummans T, et al: Guideline Watch: Practice Guideline for the Treatment of Patients With Alzheimer’s Disease and Other Dementias. Arlington, VA, American Psychiatric Association, Oct 2014. http://psychiatryonline.org/guidelinesGoogle Scholar
Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther 2014; 6:82Crossref, Google Scholar
:Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies. Can J Psychiatry 2014; 59:13–17Crossref, Google Scholar
:Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 2014; 370:322–333Crossref, Google Scholar
:The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 2014; 44:673–683Crossref, Google Scholar
:Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 2012; 367:795–804Crossref, Google Scholar
:Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol 2012; 11:669–678Crossref, Google Scholar
:Relapse risk after discontinuation of risperidone in Alzheimer’s disease. N Engl J Med 2012; 367:1497–1507Crossref, Google Scholar
:Introduction to the recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:257–262Crossref, Google Scholar
:MDS Task Force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI. Mov Disord 2011; 26:1814–1824Crossref, Google Scholar
:The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:263–269Crossref, Google Scholar
:The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013; 9:63–75.e2Crossref, Google Scholar
:Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Arch Neurol 2012; 69:215–222Crossref, Google Scholar
:Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:280–292Crossref, Google Scholar
:Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement 2011; 7:367–385Crossref, Google Scholar
:Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 2012; 11:1006–1012Crossref, Google Scholar
: